NCT06365541View on ClinicalTrials.gov

The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients

PHASE4RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients
Interventions
DRUG

Dapagliflozin

oral Dapagliflozin tablets 10mg/day for 6 months

Trial Locations (1)

525200

RECRUITING

The People's Hospital of Gaozhou, Maoming

All Listed Sponsors
lead

The People's Hospital of Gaozhou

OTHER